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A B S T R A C T
In this paper, we are presenting the two cases of very rare tumors: breast sebaceous carcinoma, which has been de-
scribed for the first time in Croatian medical literature, and pure breast squamous carcinoma. First case, sebaceous car-
cinoma, is still quite unknown regarding its morphological characteristics and biological behavior. In the second case,
squamous carcinoma, also very rare, was found in a patient who previously had a number of diagnosed head and neck
skin carcinomas, and was diagnosed as primary squamous breast carcinoma. As a first case we present a 85-year-old fe-
male with a two months history of swelling of the left breast under the mammilla. The second one, a 69-year-old female
presented to our hospital in January 2008 with a two months history of a lump in the lower outer region of the left breast
and enlarged lymph nodes in left axillary region. Fine needle aspiration cytology (FNAC) of the breast was performed in
order to diagnose the exact type of both tumours. This methodology was found important in diagnosis, but in both cases
showed certain limitations in diagnosing such rare tumors. The final diagnoses were determined after carefully synthe-
sizing the histological findings and clinical data. Careful and accurate classification of these tumors is necessary. A de-
tailed analysis of their biological behavior and response to the therapy is necessary in order to formulate definite recom-
mendations in managing these patients/diseases.
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Introduction
Fine needle aspiration cytology (FNAC) of the breast
is a standard diagnostic technique in breast malignancies
diagnostics and their further sub typing. In a number of
cases, FNAC of breast makes subtyping breast malignan-
cies possible with a high degree of accuracy. Determina-
tion of special types of breast carcinoma by fine-needle
aspiration cytology may have prognostic implications but
cytologists are still facing some difficulties in determin-
ing the tumour subtypes. At University Hospital for Tu-
mors, 3075 breast carcinomas were operated in the last 5
years. Most of them, around 75%, were ductal invasive
carcinomas (NOS), others were rarer types of carcinoma.
In this paper, we present two cases of very rare tumors:
sebaceous carcinoma and squamous carcinoma, both be-
ing described for the first time in Croatia. First case, se-
baceous carcinoma, is still quite unknown regarding the
morphological characteristics and biological behavior.
Second case, squamous carcinoma, also very rare, after a
number of previously diagnosed head and neck skin car-
cinomas, was diagnosed as primary breast carcinoma.
Case Reports
Case 1
A 85-year-old female had a 2 months history of swell-
ing of the left breast under the mammilla, and in Febru-
ary 2008, visited our Hospital. Segmentectomy was per-
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formed after US guided FNAC. The aspirates showed a
lot of clusters and single, mostly uniform cells with visi-
ble clear cytoplasmatic vacualization and coarse cro-
matin structure (Figures 1 and 2). Cytology diagnosis
wasn’t specific, because it could include several diagno-
ses: sebaceous carcinoma, lipid cell carcinoma and apo-
crine carcinoma. A gross examination revealed a tumor
measuring 2.5 cm with its portion reaching the excision
margin, without any skin tissue. Histologically, the tu-
mor was made of loose connective tissue stroma with
solid clusters of large cells of markedly light-colored cyto-
plasm and areas of squamous morulas (Figure 3). Histol-
ogy could not distinguish whether this was a primary
sebaceal carcinoma of the breast or of the skin. Immuno-
histochemistry showed negative reaction for ER, PR and
HER2/neu.
After 10 months the patient came with a new swelling
under the postoperative scar. The cytology presentation
of the smears was the same as previous one and mastec-
tomy was performed. This time, tumor was 5 cm in diam-
eter and histology was the same as the previous one. The
lesion had no connection to the overlying skin or the nip-
ple. Immunohistochemically, the tumor cells were posi-
tive for AE1/AE3 (Dako, Glostrup) (Figure 4) and a nega-
tive for GCDFP-15 (Figure 5), ER, PR and HER-2/neu.
MIB-1 labeling index was approximately 25%. The histo-
pathological diagnosis qualified this carcinoma as seba-
ceous carcinoma of the breast.
Case 2
A 69-year-old female presented to our hospital in Jan-
uary 2008 with a two months history of a lump in the
lower outer region of the left breast and enlarged lymph
nodes in left axillary region. Ultrasonography revealed a
cystic tumor and FNAC aspiration under USG control
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Fig. 1. Clusters and rare single, fairly uniform cells with abun-
dant finely vacuolated cytoplasm. May-Grünwald-Giemsa, x100.
Fig. 2. Sebaceous carcinoma. May-Grünwald-Giemsa, x400.
Fig. 3. The lobules are made up predominantly of large clear or
multivacuolated cells. admixed with minor non-vacuolated epi-
thelial cells. Hematoxylin and eosin, x100.
Fig. 4. IHC staining is positive for pan CK, x200.
Fig 5. IHC staining is negative for GCDFP-15, x100.
was performed. The skin and the nipple-areola complex
were not involved.
Aspiration smears were characterized by squamous
cells, both isolated and in aggregates, at various stages of
maturation. The tumour cells showed hyperchromatic
nuclei and eosinophilic cytoplasm (Figure 6). The smear
background showed inflammation and necrosis. Cytolog-
ical diagnosis was suggestive of squamous cell carci-
noma. Segmentectomy with axillar dissection was per-
formed. Histopathology showed ill-defined grey tumor
1x1.5 cm in size, made up of conglomerates and threads
of atypical epithelial squamous cells that have had cor-
neal focus (Figure 7). Eight axillary lymph nodes were
extirpated and examined, and one of them was positive
for tumor cells with ectracapsular spreading to the fat
tissue. Tissue of the tumor had penetrated through the
lymph node capsule, invading the surrounding fat tissue.
Estrogene and progesterone receptors, and HER2/neu
receptors were negative, while CK5 was positive. Medical
history recorded that the patient underwent two exci-
sions of the skin malignant melanomas of the face in past
ten years. In the same period, the patient has had exci-
sions of four basaliomas: at the both sides of the nose, left
parotid region, and forehead. All previous findings have
been revised and the results were in accordance with the
original findings. To exclude metastatic disease, CT scan
of the abdomen and thorax was performed. Since meta-
static disease was not found, the patient was diagnosed
as primary squamous cell breast carcinoma.
Discussion
Fine needle aspiration cytology of the breast has a
high range of accuracy (72–99%)20–22 in the diagnosis of
malignancy and its sub typing. Despite this, some rare le-
sions create problems at cytodiagnosis. Accuracy of cyto-
diagnosis of malignant breast tumors is very important,
to know the exact line of treatment preoperatively. Histo-
logically, 25–30% of epithelial malignancies are in the
group of specialized breast carcinoma like lobular, papil-
lary, apocrine, tubular, cribriform, medullary, mixed and
others1. The sub typing of breast tumors using aspiration
cytology is useful, in order to decide the best type of
treatment. If tumors are of low malignant potential, op-
tions for conservative breast carcinoma treatment are
being available for the patient2. However; it is not always
possible to label the exact subtype on aspiration cytology
without correlating the clinical and histopathological
findings.
In the first case we described a very rare sebaceous
carcinoma, first case to be described in Croatian medical
literature. Sebaceous carcinoma is a rare breast carci-
noma characterized by unequivocal morphologic differ-
entiation towards sebaceous epithelium or sebocytes.
Other sites have been more widely studied and described,
most commonly, the periocular and only occasionally the
extraocular regions6. Despite the possible derivation from
a common origin of the mammary glands and skin ap-
pendages, it is notable that primary sebaceous carcinoma
of the breast is extremely rare7.
The sebaceous feature in mammary carcinomas was
initially recognized by Bogaert and Maldague (1977), and
although mammary sebaceous carcinoma was first de-
scribed as a variant of lipid-secreting carcinoma of the
breast3, the recent WHO classification of breast tumors
has recognized this type of tumor as a distinct subtype of
invasive breast carcinomas10. The number of previously
documented cases with such a peculiar mammary carci-
noma with sebaceous differentiation is still very low, and
their detailed clinicopathologic information is available
in only five examples4–6,8,11 The sebaceous differentiation
was identified in mammary adenoid cystic carcinoma by
Tavassoli and Norris (1986)1 and in mammary carcinoma
with ductal, squamous and myoepithelial elements by
Prescott et al. (1992)4 In 1999 Tavassoli first described
the mammary carcinoma with well-differentiated seba-
ceous morphology under the rubric of sebaceous carci-
noma in her monograph6. Although skin carcinomas may
also occur in the breast or involve the mammary gland,
such lesions should not be included in the category of
mammary sebaceous carcinoma12.
Microscopically, the carcinoma is essentially charac-
terized by a lobular or nested growth pattern of tumor
cells variably admixed with those displaying sebaceous
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Fig. 6. Well differentiatet malignant epithelial cells.
May-Grünwald-Giemsa, x100.
Fig. 7. Well differentiated Squamous cell cancer.
Hematoxylin and eosin, x100.
differentiation6,10. Our case, similar to the case described
by Hisaoka et al.11 showed distinct, well-delineated solid
and lobular structures without other histological ele-
ments such as squamous and myoepithelial cells or in
situ components.
Immunohistochemical expression of cytokeratin was
positive like in all described cases but there were nega-
tive reaction for GCDFP-15, ER, PR and HER2/neu
which was different in other five described cases.
The extend of the sebaceous morphology differed
among the reported cases4–8,11, and the criteria of mam-
mary sebaceous carcinoma seem ambiguous at this
point6,10. The origin of sebaceous cells in breast carci-
noma and their biological behavior is still unclear.
In the second case we described squamous carcinoma
of the breast which is a rare disorder, accounting for an es-
timated 0.04 to 0.075% of all breast malignancies10,15,18,22.
The first case was reported in 1908 and till now about
one hundred cases of SCC have been reported13. The cri-
teria to define »pure» squamous cell Ca of the breast are:
1) that no other neoplastic elements such as ductal or
mesenchymal ones are present in the tumor; 2) that the
tumor is independent of adjacent cutaneous structure; 3)
that no other distant epidermoid tumor exists in the
patient14. Metastatic SCC from lung, the oral cavity, cer-
vix and esophagus and the skin was excluded in our pa-
tient, and the diagnosis of SCC of the breast was initially
suggested by fine aspiration cytology.
The origin of this tumor is controversial; it has been
stated as arising from dermatoid cyst of the breast,
chronic abscesses, and complete metaplasia of glandular
breast tissue14.
SCC of the breast is a tumor of elderly age group15.
Tumors frequently reach large volumes and can be as
large as 5 cm16. Our patient was 69 years old and she has
had a mass smaller than the others, measured 1.5 cm.
These tumors are usually estrogen and progesterone
negative and the same thing was with our patient, so
hormonal adjuvant therapy could not be performed. How-
ever, if they are receptor positive, tamoxifen should be
the adjuvant therapy of choice. Receptor negative pa-
tients may require adjuvant chemotherapy, especially if
they are premenopausal. The role of adjuvant radiother-
apy has not been extensively studied but may have an
important role in breast treatment management19. Sma-
ller primary SCC of the breast could be treated with
lumpectomy with dissection followed by radiotherapy17.
In our case, a small tumor was detected, our patient un-
derwent segmentectomy and axillary dissection, followed
by radiotherapy. In a report of Menes et al.13 SCC was
found to be associated with lower rate of lymph node me-
tastasis at presentation (22% vs. 40–60% for infiltrating
ductal carcinoma) and a significant rate of distant metas-
tasis without lymph node involvement. This is in contra-
diction to squamous cell carcinomas appearing at other
parts of body which metastasise frequently to regional
lymph nodes. Our patient had one positive lymph node.
She is now in 14 months in routine follow up and did not
have local recidive or metstatic disease until now. Despite
the rarity of this neoplasia, it should be kept in mind that
within a cystic mass of the breast, in older patients, a
squamous cell carcinoma could be found.
Conclusion
Sebaceous and squamous carcinomas are rare breast
carcinomas. Their prognosis and appropriate treatment
approach are still debated. Therefore, new case reports
would help in determining the right approach to these
diseases. The origin of sebaceous cells in breast carci-
noma is still unclear. Most common sebaceous carcino-
mas arising in extramammary sites are aggressive tu-
mors. The prognostic significance connotation of the
sebaceous phenotype in breast carcinoma remains un-
clear due to this peculiar variant.
Regarding the squamous cell carcinoma, its existence
and possible evolution of an apparently benign disorder
to malignant one, underlines the importance of patholog-
ical examination of complicated cysts and breast ab-
scesses. Careful and accurate classification of these tu-
mors is necessary. A detailed analysis of their biological
behavior and response to therapy is necessary in order to
formulate definite recommendations in managing these
patients/diseases.
R E F E R E N C E S
1. JOSHI A, MAIMOON S, J Cytol, 24 (2007) 2003. — 2. SHROFF P, J
Cytol, 15 (1998) 18. — 3. VAN BOGAERT LJ, MALDAGUE P, Virchows
Arch Pathol Anat, 375 (1977) 345. — 4. PRESCOTT RJ, EYDEN BP,
REEVE NL, Hystopathology, 21 (1992) 181. — 5. MAZZELA FM, SIE-
BER SC, BRAZA F, Pathology, 27 (1995) 280. — 6. TAVASSOLI FA, Pa-
thology of the breast (2nd edition Appleton and Lange, Stamford, 2006).
— 7. TAVASSOLI FA, NORRIS HJ, Arch Pathol Lab Med, 110 (1986)
1045. — 8. VARGA Z, KOLB SA, FLURY R, BURKHARD R, CADUFF R,
Pathol Int, 50 (2000) 63. — 9. MASANORI FA, YUJI T, YUTAKA H, HI-
RONOBU M, TETSUO H, Virchows Arch, 449 (2006) 484. — 10. TAVA-
SSOLI FA, DEVILEE P, World Health Organization classification of tu-
mours: tumours of the breast and female genital organs (IARC, Lyon,
2003) — 11. HISAOKA M, TAKAMATSU YUJI, HIRANO Y, MAEDA H,
HAMADA T, Virchows Arch, 449 (2006) 484. — 12. ALZARAA A, GHA-
FOOR I, YATES A, DHEBRI A, J Med Case Reports, 2 (2008) 276. — 13.
MENES T, SCHACHTER J, MORGENSTERN S, FENIG E, LURIE H,
GUTMANH, Am J Clin Oncol, 26 (2003) 571. — 14. PRICOLO R, CROCE
P, VOLTOLINI F, PATIES C, SCHENA C, Miner Chir, 46 (1991) 215. —
15. BEHRANWALA KA, NASIRI N, ABDULLAHN, TROTT PA, GUI GP,
Eur J Surg Oncol, 29 (2003) 386. — 16. EUSEBI V, LAMOVEC J, CAT-
TANI MG, FEDELI F, MILLIS RR, Am J Surg Pathol, 10 (1986) 855. —
17. SINGH H, WILLIAMS SP, KINSELLA V, LYNCH GR, Cancer Invest,
18 (2000) 343. — 18. FLIKWEERT ER, HOFSTEE M, LIEM SL, World J
Surg Oncol, 6 (2008) 135. — 19. PRAMESH CS, CHATURVEDI P, SA-
KLANI AP, BADWE RA, J Postgrad Med, 47 (2001) 270. — 20. FRAN-
CEN S, ZAICEK J, Acta Radiol Ther Physics Biol, 7 (1968) 241. — 21.
BIBBO M, Comprehensive cytopathology (WB Saunders company, Phila-
delphia, 1997). — 22. RAMLJAK V, RANOGAJEC I, BULIMBA[I] S, Ci-
tologija tumora dojke. In: SAMIJA M, JUZBASIC S, SEPAROVIC V, VR-
DOLJAK DV (Eds) Tumori dojke (Medicinska naklada, Zagreb, 2007).
V. Ramljak
V. Ramljak et al.: FNA and Rare Breast Tumours, Coll. Antropol. 34 (2010) 1: 201–205
204
Department of Cytology, University Hospital for Tumors, Zagreb Croatia
e-mail: vesna.ramljak@kzt.hr
CITODIJAGNOZA RIJETKIH TUMORA DOJKE – PRIKAZ SLU^AJEVA
S A @ E T A K
U ovom radu predstavljamo dva slu~aja vrlo rijetkih tumora dojke: rak lojnih `lijezda dojke, koji se po prvi puta
opisuje u hrvatskoj medicinskoj literaturi, te ~isti plo~asti karcinom dojke. U prvom slu~aju, karcinom lojnica je jo{
uvijek dosta nepoznat u pogledu morfolo{kih karakteristika i biolo{kog pona{anja. U drugom slu~aju, plo~asti karcinom
je tako|er vrlo rijedak, a u pacijentice je otkriven nakon ranijih brojnih karcinoma na ko`i glave i vrata, te dijagno-
sticiran kao primarni plo~asti karcinom dojke. U prvom slu~aju predstavljamo 85 godi{nju `enu u ~ijoj povijesti bolesti
unatrag dva mjeseca nalazimo ~vor u lijevoj dojci ispod mamile. Drugi slu~aj, 69 godi{nje `ene zapo~inje u sije~nju 2008,
kada dolazi nakon {to je prije dva mjeseca primijetila ~vor u donjem vanjskom kvadrantu lijeve dojke sa uve}anjem
limfnih ~vorova lijeve aksilarne regije. Kako bi se odredio precizan tip tumora, u oba slu~aja u~inila se punkcija dojke
pod kontrolom ultrazvuka (FNAC). Ovo je va`na metoda za dijagnostiku, no u oba slu~aja pokazali su se njeni nedostaci
u dijagnosticiranju ovako rijetkih tumora. Kona~na dijagnoza utvr|ena je nakon pa`ljive sinteze citolo{kih i histolo{kih
rezultata te klini~kih podataka. Nu`na je pa`ljiva i to~na klasifikacija ovih tumora kao i detaljna analiza njihovih bio-
lo{kih karakteristika te odgovora na terapiju kako bi se formulirale kona~ne smjernice za postupanje/lije~enje ovih
bolesnika/bolesti.
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